GlaxoSmithKline Plc ADR (GSK)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Emma N. Walmsley
Employees:
90,100
980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, X0, TW8 9GS
011442080475000

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital.

Data derived from most recent annual or quarterly report
Market Cap 74.044 Billion Shares Outstanding2.047 Billion Avg 30-day Volume 4.256 Million
P/E Ratio11.4344 Dividend Yield6.1474 EPS
Price to Revenue1.9278 Debt to Equity1.3048 EBITDA11.109 Billion
Price to Book Value4.5065 Operating Margin22.8247 Enterprise Value121.875 Billion
Current Ratio0.914 EPS Growth0.232 Quick Ratio0.605
1 Yr BETA 0.4048 52-week High/Low 46.41 / 28.19 Profit Margin18.7337
Operating Cash Flow Growth8.4766 Altman Z-Score1.5084 Free Cash Flow to Firm 11.819 Billion

Are you looking for this stock instead?

View SEC Filings from GSK instead.

Funds Holding GSK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GSK

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
GSK PLC-SPON ADR GSK 2023-02-08 20:15:04 UTC 4.0729 0.4971 3700000
GSK PLC-SPON ADR GSK 2023-02-08 19:45:03 UTC 4.0729 0.4971 3700000
GSK PLC-SPON ADR GSK 2023-02-08 19:15:04 UTC 4.0729 0.4971 3700000
GSK PLC-SPON ADR GSK 2023-02-08 18:45:03 UTC 4.1029 0.4671 3700000
GSK PLC-SPON ADR GSK 2023-02-08 18:15:03 UTC 4.1029 0.4671 3700000
GSK PLC-SPON ADR GSK 2023-02-08 17:45:03 UTC 4.1029 0.4671 3700000
GSK PLC-SPON ADR GSK 2023-02-08 17:15:03 UTC 4.1029 0.4671 3700000
GSK PLC-SPON ADR GSK 2023-02-08 16:45:03 UTC 4.1029 0.4671 3700000
GSK PLC-SPON ADR GSK 2023-02-08 16:15:03 UTC 4.1029 0.4671 3700000
GSK PLC-SPON ADR GSK 2023-02-08 15:45:03 UTC 4.1029 0.4671 3700000
GSK PLC-SPON ADR GSK 2023-02-08 15:15:04 UTC 4.1029 0.4671 3700000
GSK PLC-SPON ADR GSK 2023-02-08 14:45:04 UTC 4.1029 0.4671 3300000
GSK PLC-SPON ADR GSK 2023-02-08 14:15:04 UTC 4.1029 0.4671 3300000
GSK PLC-SPON ADR GSK 2023-02-08 13:45:04 UTC 4.1619 0.4081 3300000
GSK PLC-SPON ADR GSK 2023-02-08 13:15:03 UTC 4.1619 0.4081 3300000
GSK PLC-SPON ADR GSK 2023-02-08 12:45:04 UTC 4.1619 0.4081 3300000
GSK PLC-SPON ADR GSK 2023-02-07 22:15:03 UTC 4.1619 0.4081 3300000
GSK PLC-SPON ADR GSK 2023-02-07 21:45:03 UTC 4.1619 0.4081 3300000
GSK PLC-SPON ADR GSK 2023-02-07 21:15:03 UTC 4.1619 0.4081 3300000
GSK PLC-SPON ADR GSK 2023-02-07 20:45:04 UTC 4.1619 0.4081 3300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund GSK -39758.0 shares, $-1170077.94 2022-09-30 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund GSK -2968.0 shares, $-98448.56 2022-10-31 N-PORT

Congressional Transactions Past 6-Months

To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
representative Virginia Foxx republican House Filing 2022-08-16 2022-08-16 JT P $1,001-$15,000
representative Virginia Foxx republican House Filing 2022-08-10 2022-08-10 JT P $15,001-$50,000
representative Virginia Foxx republican House Filing 2022-08-09 2022-08-09 JT P $1,001-$15,000

Elevate your investments